Thanks rusty for the infomation , I have been under the belief that medgate was a seamless experience for the patient. Apparantly not which is a huge disappoint.
basicaly it was answer a few promts (yes or no ) then patient was automaticaly directed to resappdx cough test.
the sooner we have a shareholder meeting the better for mine as the last one where we could physically be in the room was sydney 2 years ago which I flew from perth to attend . I have had a sizable investment in this company on the strength of the technology since 2015 and have like most increased my holding to average down my average price . This has been done purely becouse of the share price fluctuations over the last few years , I am looking fwd to the next shareholder meeting as like most I have questions That I would like answered.
Ann: Alodokter to launch ResAppDx in Indonesia, page-377
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #